New study tracks amulet Device's Real-World success in preventing strokes

NCT ID NCT05997446

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes over 600 people with atrial fibrillation who received the Amulet device to close a part of the heart called the left atrial appendage. The goal is to see how well the device prevents strokes and bleeding in everyday medical practice. Participants are followed for 24 months to track safety and effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arizona Arrhythmia Research

    Phoenix, Arizona, 85016, United States

  • Arkansas Heart Hospital

    Little Rock, Arkansas, 72211, United States

  • Baptist Medical Center

    Jacksonville, Florida, 32207, United States

  • Baylor All Saints Medical Center at Fort Worth

    Fort Worth, Texas, 76104, United States

  • Bryan Heart

    Lincoln, Nebraska, 68506, United States

  • CHI Health Creighton University Medical Center-Bergan Mercy

    Omaha, Nebraska, 68124, United States

  • Cardiovascular Research Institute of Kansas

    Wichita, Kansas, 67226, United States

  • Heart Rhythm Associates

    Shenandoah, Texas, 77380, United States

  • Kansas City Cardiac Arrhythmia Research Foundation

    Overland Park, Kansas, 66211, United States

  • New York University Hospital

    New York, New York, 10016, United States

  • PERC - O'Fallon

    O'Fallon, Illinois, 62269, United States

  • Pinnacle Health System

    Mechanicsburg, Pennsylvania, 17150, United States

  • Providence Hospital

    Southfield, Michigan, 48075, United States

  • Trident Medical Center

    Charleston, South Carolina, 29406, United States

  • Usman R. Siddiqui, MD

    Winter Park, Florida, 32792, United States

  • Vanderbilt Heart & Vascular Institute

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.